FDA Inspection
American Reproductive Centers, Inc.American Reproductive Centers, Inc. – FDA Inspection, Feb 22, 2019
Record Details
This FDA Inspection record concerns American Reproductive Centers, Inc., with an inspection on February 22, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d5e9ad4d-f080-4817-b0f8-425a3b67775b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1071745
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American Reproductive Centers, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 5, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 1, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 12, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for American Reproductive Centers, Inc.
- FDA Inspection 1006283 - 2016-12-05
- FDA Inspection 928580 - 2015-06-01
- FDA Inspection 895828 - 2014-09-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.